Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 May;13(5):435-9.
doi: 10.1007/s12603-009-0080-3.

C-reactive protein and fibrinogen of bedridden older patients in a six-month vitamin D supplementation trial

M P Bjorkman  1 , A J Sorva, R S Tilvis
Affiliations
Randomized Controlled Trial

C-reactive protein and fibrinogen of bedridden older patients in a six-month vitamin D supplementation trial

M P Bjorkman et al. J Nutr Health Aging. 2009 May.

Abstract

Objective: To elucidate the association between vitamin D status, C-reactive protein (CRP) and fibrinogen.

Design: Secondary analysis of a randomised double-blind placebo controlled trial.

Setting: Four longterm care hospitals (1215 beds) in Helsinki, Finland.

Participants: 218 long-term inpatients aged over 65 years.

Intervention: Eligible patients (n = 218) were randomized to receive 0 IU/d, 400 IU/d, or 1200 IU/d cholecalciferol for six months.

Methods: Plasma 25-hydroxyvitamin D (25-OHD), parathyroid hormone (PTH), high sensitive CRP, fibrinogen, amino-terminal propeptide of type I procollagen (PINP), and carboxy-terminal telopeptide of type I collagen (ICTP) were measured.

Results: The patients were aged (84.5 +/- 7.5 years), vitamin D deficient (25-OHD = 23 +/- 10 nmol/l), chronically bedridden and in stable general condition. The mean baseline CRP and fibrinogen were 10.86 mg/l (0.12 mg/l - 125.00 mg/l) and 4,7 g/l (2.3 g/l - 8.6 g/l), respectively. CRP correlated with ICTP (r = 0.217, p = 0.001), but not with vitamin D status. Supplementation significantly increased 25-OHD concentrations, but the changes in CRP and fibrinogen were insignificant and inconsistent. The post-trial CRP concentrations (0.23 mg/l -138.00 mg/l) correlated with ICTP (r = 0.156, p < 0.001), but no association was found with vitamin D status. The baseline and post-trial fibrinogen correlated with CRP, only.

Conclusions: CRP concentrations are associated with bone turnover, but not with vitamin D status, and vitamin D supplementation has no major effect on CRP or fibrinogen concentrations in bedridden older patients.

PubMed Disclaimer

References

    1. Holick M.F. Vitamin D deficiency. N Engl J Med. 2007;357:266–281. 10.1056/NEJMra070553 17634462. - DOI - PubMed
    1. Canning M.O., Grotenhuis K., de Wit H., Ruwhof C., Drexhage H.A. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol. 2001;145:351–357. 10.1530/eje.0.1450351 11517017. - DOI - PubMed
    1. McCarty M.F. Secondary hyperparathyroidism promotes the acute phase response — a rationale for supplemental vitamin D in prevention of vascular events in the elderly. Med Hypotheses. 2005;64:1022–1026. 10.1016/j.mehy.2004.03.041 15780504. - DOI - PubMed
    1. Zhu Y., Mahon B.D., Froicu M., Cantorna M.T. Calcium and 1alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol. 2005;35:217–224. 10.1002/eji.200425491 15593122. - DOI - PubMed
    1. Oelzner P., Müller A., Deschner F., et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int. 1998;62:193–198. 10.1007/s002239900416 9501950. - DOI - PubMed

Publication types

MeSH terms